"Solvency II is more complex than it should have been" - Montalvo

The Eiopa chief says demands for increasing granularity have added complexity but the directive's core principle is solid - and the 2014 start date can still be met. Lorna Davies reports


What is the future for supplementary reporting?

With the onset of Solvency II and IASB/FASB Phase II, supplementary reporting needs to adapt. Kamran Foroughi explains the background to this in the context of life insurers' reporting under EEV/MCEV principles in 2010.


Eiopa delays guidance on USPs

USPs should be attractive for many insurers in Europe, but some experts say regulators need to make the rules more flexible and clarify a number of points. Eiopa instead is delaying an expected consultation on the subject.


Bernardino: "Two-year transitional adequate for hybrid debt"

Speaking exclusively to InsuranceERM, chairman of Eiopa Gabriel Bernardino dismisses criticisms that Solvency II will damage the insurance industry but says fine tuning is needed. Michael Faulkner reports.


EIOPA announces insurance stress test in second quarter

Will cover 50% of companies in each country


Bernardino to be EIOPA's first chairperson

Gabriel Bernardino, chairman of CEIOPS from October 2009 to December 2010, has been elected the first chairperson of EIOPA by the authority's board of supervisors.


EIOPA elects first management board

Van Hulle counting on EIOPA for the right conclusions from QIS5


Solvency II level 3 pre-consultations to be in private

No public debate at this stage on internal model issues


EIOPA board of supervisors meets 10 January

Will formalize new body's establishment


The year in headlines

Here's a snapshot of some of the main developments in 2010, as captured by headlines from our news and comment section. There were some big natural disasters but no landfalling hurricane in the US, confounding some of the dire predictions. QIS5 featured large, along with other moves towards installing the Solvency II regime and tightening regulation of banking and insurance generally. The longevity risk transfer market is developing, but more slowly than anticipated by some.